| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |